HOME >> BIOLOGY >> NEWS
Discovery of gene will likely lead to new treatments for inflammatory diseases, cancer

(Boston) -- In a paper featured today in Proceedings of the National Academy of Science (PNAS), researchers from Boston University School of Dental Medicine report the discovery of a new gene, STAT6(B), that helps regulate production of the potentially deadly tumor necrosis factor alpha (TNF-alpha) cytokine. TNF-alpha is involved in inflammatory disorders such as Crohn's disease, rheumatoid arthritis, and irritable bowel syndrome. The paper is the first by a dental school researcher to be chosen as a featured article in PNAS.

The new gene also regulates vascular endothelial growth factor (VEGF), which is responsible for new blood vessels. Blocking excess amounts of VEGF has already led to the cancer therapeutic Avastin; STAT6(B) works through a different mechanism and thus will offer new opportunities for treating cancer. The researchers are publishing this finding in a separate paper.

STAT6(B), which is similar to the previously known STAT6 gene, works closely with a gene known as LITAF, discovered by the same Boston University researchers in 1999. The STAT6(B) and LITAF proteins (which are coded for by their respective genes) bind to form a complex that moves into the cell's nucleus to regulate the transcription of cytokines. The recent Boston University findings will offer new ways to regulate TNF-alpha, whose overexpression causes inflammatory and immunological problems.

Drugs regulating TNF-alpha such as Remicade, Embrel, and Humira are a multibillion dollar market. "Because STAT6(B) and LITAF affect TNF-alpha through a different pathway, we expect to develop more efficient therapeutics to help people with rheumatoid arthritis, Crohn's disease, and inflammatory bowel syndrome," says Boston University School of Dental Medicine Professor Salomon Amar, the leading author of the paper.

The Boston University researchers are now working on animal models to control LITAF and thus TNF-alpha overproduction in inflammatory syndromes. <
'"/>

Contact: Mari Megias
megias@bu.edu
617-638-5147
Boston University
28-Mar-2005


Page: 1 2

Related biology news :

1. Discovery of new protein could provide new understanding of male fertility
2. Discovery in plant virus may help prevent HIV and similar viruses
3. Discovery could help bring down price of DNA sequencing
4. Discovery in orange cauliflower may lead to more nutritious crops
5. Discovery of new family of pseudo-metallic chemicals
6. Discovery in plants suggests entirely new approach to treating human cancers
7. Discovery of master switch for the communication process between chloroplast and nuclei of plants
8. Discovery of new cave millipedes casts light on Arizona cave ecology
9. Discovery of chemical profiles for infectious diarrhea
10. Discovery could lead to better control of hemorrhagic fever viruses
11. Honey bee researcher wins National Research Initiative Discovery Award

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/4/2019)... , ... October 04, 2019 , ... ... will be held November 10 at the Grand Elysée Hamburg Rothenbaumchaussee in Hamburg. ... Europe again this November,” said Miao Guo, Vice President of Operations and spokesperson ...
(Date:10/3/2019)... ... October 01, 2019 , ... The ... of chemicals, reagents, and medias and to be a more environmentally sustainable evolution ... culmination of years of experience and feedback from the original version we launched ...
(Date:10/3/2019)... ... 02, 2019 , ... Connecticut Innovations (CI), Connecticut’s strategic venture ... innovative, growing companies, today announced that it has closed on a $750,000 investment ... the 2018 VentureClash competition. , The outlay is part of ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... ... October 02, 2019 , ... Rapid Novor, Inc., ... announce that it has moved into a new, 5000 sqft, purpose-built, state-of-the-art facility. ... facility demonstrates the company's continuous commitment to quality research and service offerings. ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer ... focused on the development of therapies to treat central nervous system (CNS) ...
(Date:9/17/2019)... ... 2019 , ... Catalent, a global leader in clinical supply ... Pacific (APAC) will present at the upcoming 3rd Annual Accelerating Clinical Trials in ... Thursday, Sept. 26, at 10:10 a.m., Ms. Delaney will present “Singapore: APAC’s Clinical ...
(Date:9/17/2019)... (PRWEB) , ... September 16, 2019 , ... ... Nationwide via CNBC on Saturday, September 21st @11:00am ET. Check local listings for ... Pte. Ltd. (Credo Biomedical), a molecular diagnostic company from Singapore dedicated to ...
Breaking Biology Technology:
Cached News: